Teladoc Health (TDOC) analyst forecast and price target
Analyst forecast
Consensus of 24 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Neutral | $7.50 from $11.00 | Aug 3, 2026 |
| Evercore ISI Group | Maintained | In-Line | $7.50 from $10.00 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $10.00 from $11.00 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $11.00 from $10.00 | Jul 21, 2026 |
| B of A Securities | Maintained | Buy | $10.50 from $9.00 | Jul 7, 2026 |
| Citigroup | Maintained | Neutral | $7.00 from $6.00 | May 5, 2026 |
| Evercore ISI Group | Maintained | In-Line | $6.00 from $5.00 | Apr 8, 2026 |
| Barclays | Maintained | Equal-Weight | $7.00 from $8.50 | Mar 26, 2026 |
| JP Morgan | Maintained | Neutral | $7.00 from $9.00 | Mar 13, 2026 |
| Deutsche Bank | Upgraded | Hold → Buy | $11.00 | Mar 10, 2026 |
| Oppenheimer | Maintained | Outperform | $7.00 from $12.00 | Mar 3, 2026 |
| Citigroup | Maintained | Neutral | $6.00 from $9.00 | Mar 3, 2026 |
| Stifel | Maintained | Hold | $6.00 from $8.00 | Feb 26, 2026 |
| Evercore ISI Group | Maintained | In-Line | $5.00 from $8.00 | Feb 26, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $6.00 from $8.00 | Feb 26, 2026 |
| Piper Sandler | Maintained | Overweight | $9.00 from $12.00 | Feb 26, 2026 |
| BMO Capital | Maintained | Market Perform | $5.00 from $8.00 | Feb 26, 2026 |
| TD Cowen | Maintained | Hold | $6.00 from $8.00 | Feb 26, 2026 |
| Leerink Partners | Maintained | Market Perform | $5.50 from $8.50 | Feb 26, 2026 |
| Canaccord Genuity | Maintained | Buy | $10.00 from $12.00 | Feb 26, 2026 |
Frequently asked questions
What is the price target for TDOC stock?
The average 12-month analyst price target for Teladoc Health (TDOC) is $8.88, with a high estimate of $10.50 and a low of $7.50, across 4 analysts.
Is TDOC a buy, sell, or hold?
Analysts covering Teladoc Health currently average a Hold rating: 5 buy, 19 hold and 0 sell, from 24 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for TDOC?
The average price target of $8.88 implies 39.98% upside from the last price of $6.34.
What is the latest analyst rating on TDOC?
On Aug 3, 2026, Citigroup maintained Teladoc Health at Neutral with a price target of $7.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.